跳至主要内容
临床试验/JPRN-UMIN000048684
JPRN-UMIN000048684已完成未知

Validation research study on migraine (Validation research study using questionnaire surveys and health insurance association medical claim data) - Validation research study on migraine

Otsuka Pharmaceuticals Co., Ltd0 个研究点目标入组 21,480 人开始时间: 2022年9月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
21,480

研究概览

简要总结

sing a questionnaire linked claim data,we examined the most appropriate receipt conditions for migraine subjects identified by the ICHD-3 and 2 screeners.The most common combination of the PPV was "at least two migraine diagnoses and at least one prescription of migraine prophylaxis or triptans in the same month as the migraine diagnosis", suggesting that these were appropriate conditions for the migraine patients identified in the ICHD-3 condition

研究设计

研究类型
Observational

入排标准

年龄范围
19years-old 至 74years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
Otsuka Pharmaceuticals Co., Ltd

相似试验